Instituto Universitario de Investigaciones en Ciencias de la Salud, Universidad de las Islas Baleares, Palma de Mallorca, Spain.
Antimicrob Agents Chemother. 2011 Oct;55(10):4742-7. doi: 10.1128/AAC.00309-11. Epub 2011 Aug 1.
Clinical isolates of Klebsiella pneumoniae resistant to carbapenems are being isolated with increasing frequency. Loss of the expression of the major nonspecific porins OmpK35/36 is a frequent feature in these isolates. In this study, we looked for porins that could compensate for the loss of the major porins in carbapenem-resistant organisms. Comparison of the outer membrane proteins from two K. pneumoniae clinical isogenic isolates that are susceptible (KpCS-1) and resistant (KpCR-1) to carbapenems revealed the absence of OmpK35/36 and the presence of a new 26-kDa protein in the resistant isolate. An identical result was obtained when another pair of isogenic isolates that are homoresistant (Kpn-3) and heteroresistant (Kpn-17) to carbapenems were compared. Mass spectrometry and DNA sequencing analysis demonstrated that this new protein, designated OmpK26, is a small monomeric oligogalacturonate-specific porin that belongs to the KdgM family of porins. Insertion-duplication mutagenesis of the OmpK26 coding gene, yjhA, in the carbapenem-resistant, porin-deficient isolate KpCR-1 caused the expression of OmpK36 and the reversion to the carbapenem-susceptible phenotype, suggesting that OmpK26 is indispensable for KpCR-1 to lose OmpK36 and become resistant to these antibiotics. Moreover, loss of the major porin and expression of OmpK26 reduced in vitro fitness and attenuated virulence in a murine model of acute systemic infection. Altogether, these results indicate that expression of the oligogalacturonate-specific porin OmpK26 compensates for the absence of OmpK35/36 and allows carbapenem resistance in K. pneumoniae but cannot restore the fitness of the microorganism.
临床分离的耐碳青霉烯类肺炎克雷伯菌的发生率正在不断增加。这些分离株的一个常见特征是主要非特异性孔蛋白 OmpK35/36 的表达缺失。在本研究中,我们寻找可以补偿耐碳青霉烯类药物的生物体中主要孔蛋白缺失的孔蛋白。比较对碳青霉烯类药物敏感(KpCS-1)和耐药(KpCR-1)的两种肺炎克雷伯菌临床同源分离株的外膜蛋白,发现耐药分离株中缺乏 OmpK35/36,存在一种新的 26kDa 蛋白。当比较另一对同源耐药(Kpn-3)和异源耐药(Kpn-17)的碳青霉烯类药物的同源分离株时,得到了相同的结果。质谱和 DNA 测序分析表明,这种新的蛋白,命名为 OmpK26,是一种小的单体寡半乳糖醛酸盐特异性孔蛋白,属于 KdgM 家族的孔蛋白。在耐碳青霉烯类药物、缺乏孔蛋白的 KpCR-1 分离株中,OmpK26 编码基因 yjhA 的插入-缺失突变导致 OmpK36 的表达和对碳青霉烯类药物的敏感性表型的恢复,表明 OmpK26 对于 KpCR-1 缺失 OmpK36 并对这些抗生素产生耐药性是不可或缺的。此外,主要孔蛋白的缺失和 OmpK26 的表达降低了体外适应性,并减弱了急性全身感染小鼠模型中的毒力。总之,这些结果表明,寡半乳糖醛酸盐特异性孔蛋白 OmpK26 的表达可以补偿 OmpK35/36 的缺失,使肺炎克雷伯菌对碳青霉烯类药物产生耐药性,但不能恢复微生物的适应性。